The Purpose of This Clinical Study is to Evaluate Optimized Maximum Plus for Maximum Visual Acuity (MPMVA) Refractive Technique and Its Effect on Visual Performance.
Recruiting now
Conditions studied: Visual Outcome
In brief
This is a prospective, multicenter, parallel groups, non-interventional, examiner masked, comparative clinical study. Patients that participated in previous Hoya studies, and patients previous implanted with Hoya non-toric monofocal IOLs (sub-study only) will be enrolled in the study. The sample size for this study is based on demonstrating the non-inferiority of the mean distance-corrected intermediate visual acuity (DCIVA) in Group 1 (Site 1) compared with Group 2 (Site 2).
Key facts
- Study ID
- NCT07595432
- Run by
- Hoya Surgical Optics, Inc.
- People needed
- 140
- Starts
- 2026-05-13
- Expected to finish
- 2026-11-30
- Last updated by the study team
- 2026-06-04
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Main study:
- Previously implanted with intraocular lens through 2 previous IOL studies;
- Clear intraocular media with no clinically significant opacity, in the investigator's judgment, that would affect visual acuity;
- Able to provide informed consent and complete all required study procedures.
- Exploratory sub-study:
- Additional inclusion criteria: Pseudophakic eyes implanted with one of the IOLs in one eye from 3 previous IOL studies
You may not qualify if…
- Main study:
- Corrected distance visual acuity (CDVA) worse than 0.2 logMAR (or 20/32 Snellen)
- Subjects with ongoing medical conditions or treatment that might impact outcomes during the study visit as determined by the investigator.
- Exploratory sub-study:
- Additional exclusion criteria: Pseudophakic eyes with oblique residual astigmatism.
Where it is running
- Peregrine Eye Laser Institute — Manila, Philippines (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.